Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies

OBJECTIVE—: Aspirin together with thienopyridine P2Y(12) inhibitors, commonly clopidogrel, is a cornerstone of antiplatelet therapy. However, many patients receiving this therapy display high on-treatment platelet reactivity, which is a major therapeutic hurdle to the prevention of recurrent thrombo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arterioscler Thromb Vasc Biol
Egile Nagusiak: Armstrong, Paul C., Hoefer, Thomas, Knowles, Rebecca B., Tucker, Arthur T., Hayman, Melissa A., Ferreira, Plinio M., Chan, Melissa V., Warner, Timothy D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2017
Gaiak:
Translational Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5405774/
https://ncbi.nlm.nih.gov/pubmed/28279968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.116.308763
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak